Concepedia

Barbara Dymek

BD

Statistics

Publications

13

Citations

446

H-Index

12

Active since

2008

Affiliations

OncoArendi Therapeutics (Poland)(Current)

Medical University of Warsaw

International Institute of Molecular and Cell Biology

Celon Pharma (Poland)

Postgraduate School of Molecular Medicine

Barbara Dymek is an author at OncoArendi Therapeutics (Poland) specializing in pharmacology, drug discovery, and enzyme inhibition.

ORCID

Publications per year

2008–2023

13

Publications

13

Heat Stress and Hormetin-Induced Hormesis in Human Cells: Effects on Aging, Wound Healing, Angiogenesis, and Differentiation

Suresh I. S. Rattan, Ricardo A. Fernandes, Dino Demirovic et al. · Dose-Response · 2008 · 100 citations · Full text

, , +17

Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells

Paulina Grygielewicz, Barbara Dymek, Anna Bujak et al. · Gastric Cancer · 2014 · 71 citations · Full text

, , +17

Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors

Roman Błaszczyk, Joanna Brzezińska, Barbara Dymek et al. · ACS Medicinal Chemistry Letters · 2020 · 38 citations · Full text

, , +8

Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma

Daria Zdżalik-Bielecka, Barbara Dymek, Paulina Grygielewicz et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 36 citations · Full text

, , +16

Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma

Marzena Mazur, Jacek Olczak, Sylwia Olejniczak et al. · Journal of Medicinal Chemistry · 2017 · 35 citations · Full text

, , +17

1–5 of 13